Our discovery of a small set genes which can modulate membrane associated E-cadherin levels, not only points the way to discovering mechanisms to control cell-cell junctions, but offers a new set of targets for targeting colon cancer. This evidence concerns the gene CDH1 and colonic neoplasm.